HIV Envelope gp120 Activates LFA-1 on CD4 T-Lymphocytes
Author Information
Author(s): Hioe Catarina E., Tuen Michael, Vasiliver-Shamis Gaia, Alvarez Yelina, Prins Kathleen C., Banerjee Sagarika, Nádas Arthur, Cho Michael W., Dustin Michael L., Kachlany Scott C.
Primary Institution: New York University School of Medicine
Hypothesis
HIV via its envelope protein gp120 exploits the T cell activation mechanism and triggers LFA-1 activation to promote its infectivity.
Conclusion
HIV-1 gp120 can directly induce LFA-1 activation on CD4 T cells, making them more susceptible to a bacterial toxin, which could be used as a therapeutic strategy.
Supporting Evidence
- HIV-1 gp120 was sufficient to trigger LFA-1 activation in naïve CD4 T cells.
- Virus p24-expressing CD4 T cells had higher levels of surface LFA-1.
- LtxA treatment led to significant reduction of viral DNA burden in HIV-infected subjects.
Takeaway
HIV can make immune cells easier to infect and also easier to kill with a special toxin, which might help in treating HIV.
Methodology
The study used planar bilayers to observe the interaction of gp120 with CD4 T cells and measured LFA-1 activation and susceptibility to LtxA.
Potential Biases
Potential bias due to the specific focus on LFA-1 activation without considering other pathways.
Limitations
The study does not address the effects of LtxA on latent HIV reservoirs or uninfected bystander cells.
Participant Demographics
The study involved CD4 T cells from healthy donors and HIV-infected subjects.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website